Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 28:22:4.
doi: 10.1186/s11658-017-0035-3. eCollection 2017.

The regulatory mechanisms of NG2/CSPG4 expression

Affiliations
Review

The regulatory mechanisms of NG2/CSPG4 expression

Emmanuel Ampofo et al. Cell Mol Biol Lett. .

Abstract

Neuron-glial antigen 2 (NG2), also known as chondroitin sulphate proteoglycan 4 (CSPG4), is a surface type I transmembrane core proteoglycan that is crucially involved in cell survival, migration and angiogenesis. NG2 is frequently used as a marker for the identification and characterization of certain cell types, but little is known about the mechanisms regulating its expression. In this review, we provide evidence that the regulation of NG2 expression underlies inflammation and hypoxia and is mediated by methyltransferases, transcription factors, including Sp1, paired box (Pax) 3 and Egr-1, and the microRNA miR129-2. These regulatory factors crucially determine NG2-mediated cellular processes such as glial scar formation in the central nervous system (CNS) or tumor growth and metastasis. Therefore, they are potential targets for the establishment of novel NG2-based therapeutic strategies in the treatment of CNS injuries, cancer and other conditions of these types.

Keywords: CSPG4; Hypoxia; Inflammation; Methylation; MiRNA; NG2; Transcription.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Known regulatory factors of NG2 (CSPG4) expression. NG2 expression underlies inflammatory cytokines and hypoxic stress and is mediated by methyltransferases, transcription factors such as Sp1, Egr1 and Pax3, and miR129-2

Similar articles

Cited by

References

    1. Pankova D, Jobe N, Kratochvilova M, Buccione R, Brabek J, Rosel D. NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells. Eur J Cell Biol. 2012;91:969–977. doi: 10.1016/j.ejcb.2012.05.001. - DOI - PubMed
    1. Stallcup WB. The NG2 proteoglycan: past insights and future prospects. J Neurocytol. 2002;31:423–435. doi: 10.1023/A:1025731428581. - DOI - PubMed
    1. Stallcup WB, You WK, Kucharova K, Cejudo-Martin P, Yotsumoto F. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression. Microcirculation. 2016;23:122–133. doi: 10.1111/micc.12251. - DOI - PMC - PubMed
    1. Wilson BS, Ruberto G, Ferrone S. Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother. 1983;14:196–201. doi: 10.1007/BF00205360. - DOI - PMC - PubMed
    1. Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, Filardo EJ, Reisfeld RA. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci U S A. 1996;93:9710–9715. doi: 10.1073/pnas.93.18.9710. - DOI - PMC - PubMed

LinkOut - more resources